Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 56501 - 56525 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Panobinostat	Approved Investigational	PIM1	5292	upregulated	panobinostat results in increased expression of PIM1 mRNA	6p21.2	A21037
Panobinostat	Approved Investigational	PIPOX	51268	upregulated	panobinostat results in increased expression of PIPOX mRNA	17q11.2	A21037
Panobinostat	Approved Investigational	PITX2	5308	upregulated	panobinostat results in increased expression of PITX2 mRNA	4q25	A21037
Panobinostat	Approved Investigational	PKDCC	91461	upregulated	panobinostat results in increased expression of PKDCC mRNA	2p21	A21037
Panobinostat	Approved Investigational	PKM	5315	upregulated	panobinostat results in increased expression of PKM mRNA	15q23	A21037
Panobinostat	Approved Investigational	PKNOX2	63876	upregulated	panobinostat results in increased expression of PKNOX2 mRNA	11q24.2	A21037
Panobinostat	Approved Investigational	PLA2G2A	5320	upregulated	panobinostat results in increased expression of PLA2G2A mRNA	1p36.13	A21037
Panobinostat	Approved Investigational	PLA2G4A	5321	upregulated	panobinostat results in increased expression of PLA2G4A mRNA	1q31.1	A21037
Panobinostat	Approved Investigational	PLA2G7	7941	upregulated	panobinostat results in increased expression of PLA2G7 mRNA	6p12.3	A21037
Panobinostat	Approved Investigational	PLAT	5327	upregulated	panobinostat results in increased expression of PLAT mRNA	8p11.21	A21037
Panobinostat	Approved Investigational	PLAU	5328	upregulated	panobinostat results in increased expression of PLAU mRNA	10q22.2	A21037
Panobinostat	Approved Investigational	PLBD1	79887	upregulated	panobinostat results in increased expression of PLBD1 mRNA	12p13.1	A21037
Panobinostat	Approved Investigational	PLCE1	51196	upregulated	panobinostat results in increased expression of PLCE1 mRNA	10q23.33	A21037
Panobinostat	Approved Investigational	PLOD2	5352	upregulated	panobinostat results in increased expression of PLOD2 mRNA	3q24	A21037
Panobinostat	Approved Investigational	PLP1	5354	upregulated	panobinostat results in increased expression of PLP1 mRNA	Xq22.2	A21037
Panobinostat	Approved Investigational	PLSCR1	5359	upregulated	panobinostat results in increased expression of PLSCR1 mRNA	3q24	A21037
Panobinostat	Approved Investigational	PLXNA2	5362	upregulated	panobinostat results in increased expression of PLXNA2 mRNA	1q32.2	A21037
Panobinostat	Approved Investigational	PLXNC1	10154	downregulated	panobinostat results in decreased expression of PLXNC1 mRNA	12q22	A21037
Panobinostat	Approved Investigational	PMEPA1	56937	upregulated	panobinostat results in increased expression of PMEPA1 mRNA	20q13.31	A21037
Panobinostat	Approved Investigational	PNP	4860	upregulated	panobinostat results in increased expression of PNP mRNA	14q11.2	A21037
Panobinostat	Approved Investigational	PODXL	5420	upregulated	panobinostat results in increased expression of PODXL mRNA	7q32.3	A21037
Panobinostat	Approved Investigational	POLI	11201	downregulated	panobinostat results in decreased expression of POLI mRNA	18q21.2	A21037
Panobinostat	Approved Investigational	POLR3G	10622	upregulated	panobinostat results in increased expression of POLR3G mRNA	5q14.3	A21037
Panobinostat	Approved Investigational	PON1	5444	downregulated	panobinostat results in decreased expression of PON1 mRNA	7q21.3	A21037
Panobinostat	Approved Investigational	POPDC3	64208	downregulated	panobinostat results in decreased expression of POPDC3 mRNA	6q21	A21037

Displaying entries 56501 - 56525 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability